Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in Nifty 2027 index review
Divi's Laboratories is in focus.
· ET Stocks, Economic Times Markets
Divi's Laboratories and TVS Motor Company have emerged as likely contenders to replace Max Healthcare Institute and HDFC Life in the Nifty index at the March 2027 review. According to Quiddity Leaderboard, this transition may lead to significant inflows estimated at around $824 million. As the review remains in its nascent phase, further alterations to the Nifty 100 rankings are also projected.
The analysis
Against that, the stock is -2.0% on the day at ₹9,393.00, and has returned +39.0% over three months. It is trading close to its 52-week high, so expectations were already elevated going in. The pharma & healthcare sector has moved +0.1% over the same period, so Divi's Laboratories is running 38.9 points ahead of its peers.
For Divi's Laboratories, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Market context
- The company directly in focus is DIVISLAB.
- Sector exposure: Pharma & Healthcare, Banks.
In this story
Related coverage
Anup Bagchi vs Sashidhar Jagdishan: How HDFC Bank’s incoming CEO pay compares with his predecessor
Banks vs NBFCs: Which stocks could benefit as RBI set to hike rates for the first time in 3 years?
Gold extends slide to ₹1.48 lakh per 10 gm in Delhi amid weak demand
FMCG Q2FY27 preview: 6 stocks HDFC Sec likes; Honasa, Nestlé, Emami, Bikaji, Britannia, Godrej Consumer - check targets
RBI MPC meeting October 2026: Why HDFC Bank, ICICI Lombard, Coal India, TCS likely to gain if bank announces rate hike?